BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23056571)

  • 1. Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells.
    Li W; Huang X; Tong H; Wang Y; Zhang T; Wang W; Dai L; Li T; Lin S; Wu H
    PLoS One; 2012; 7(10):e47040. PubMed ID: 23056571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crosstalk between β-catenin signaling and type I, type II and type III interferons in lung cancer cells.
    Bai M; Li W; Yu N; Zhang H; Long F; Zeng A
    Am J Transl Res; 2017; 9(6):2788-2797. PubMed ID: 28670369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.
    Chen L; Li M; Li Q; Wang CJ; Xie SQ
    Mol Cancer; 2013 Dec; 12():157. PubMed ID: 24325363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1 modification improves therapeutic effects of interferons on lung cancer cells.
    Chen J; Zhao J; Chen L; Dong N; Ying Z; Cai Z; Ji D; Zhang Y; Dong L; Li Y; Jiang L; Holtzman MJ; Chen C
    J Transl Med; 2015 Sep; 13():293. PubMed ID: 26351076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-β combined with all-trans retinoic acid supresses proliferation and promote apoptosis by inhibiting JAK2/STAT3 pathway in HepG2 human hepatocellular carcinoma cells].
    Zhao J; Nie W; Li W; Zhou X; Sun H; Zhu J; Chen J; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):901-5. PubMed ID: 27363269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
    Fang P; Hwa V; Rosenfeld RG
    Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
    Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
    Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
    Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
    PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
    Zou WJ; Huang Z; Jiang TP; Shen YP; Zhao AS; Zhou S; Zhang S
    Med Sci Monit; 2017 Dec; 23():6107-6113. PubMed ID: 29276937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
    J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous silencing of β-catenin and signal transducer and activator of transcription 3 synergistically induces apoptosis and inhibits cell proliferation in HepG2 liver cancer cells.
    Wang XH; Liu MN; Huang P; Xu J; Liu AY; Chen J; Lv CQ; Xu RL
    Mol Med Rep; 2015 Aug; 12(2):2263-8. PubMed ID: 25845340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
    Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
    Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
    Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
    Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner.
    Li W; Henderson LJ; Major EO; Al-Harthi L
    J Immunol; 2011 Jun; 186(12):6771-8. PubMed ID: 21562161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.